Literature DB >> 24159317

Comparison of resazurin microtiter assay performance and BACTEC MGIT 960 in the susceptibility testing of Brazilian clinical isolates of Mycobacterium tuberculosis to four first-line drugs.

Marcelo Miyata1, Fernando Rogério Pavan, Daisy Nakamura Sato, Leonardo Biancolino Marino, Mario Hiroyuki Hirata, Rosilene Fressati Cardoso, Fernando Augusto Fiúza de Melo, Clarice Queico Fujimura Leite.   

Abstract

We assessed the performance of REMA in comparison with BACTEC MGIT 960 in the susceptibility testing of 80 Mycobacterium tuberculosis clinical isolates from Clemente Ferreira Institute against four drugs. REMA proved to be a rapid and accurate method, providing excellent correlation with BACTEC MGIT 960, with the exception of results for the ethambutol drug.

Entities:  

Keywords:  Mycobacterium tuberculosis; drug susceptibility testing; tuberculosis

Year:  2013        PMID: 24159317      PMCID: PMC3804211          DOI: 10.1590/S1517-83822013005000028

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


Tuberculosis (TB) remains a serious health problem, especially in underdeveloped and developing countries (Sanchotene ). The rising incidence of drug resistant TB gives cause for concern around the world (WHO, 2010). Currently, Brazil occupies the 19th position among the 22 countries with the most cases of TB prevalence (WHO, 2010). The initial treatment for TB involves four drugs (MS/SVS, 2009): isoniazid (INH), rifampicin (RMP), pyrazinamide (PZA) and ethambutol (EMB). Big cities such as São Paulo have high population densities and the high human immunodeficiency virus (HIV) infection rates and large numbers of institutionalized and homeless people contribute to the high prevalence of TB (Ferrari ). In this population, other factors contribute to the number of TB cases, such as irregular supply of drugs, unsuitable medical prescriptions and abandonment of treatment (Vareldzis ). Low-cost, sustainable and accessible methods (Ferrari ) that also exhibit high sensitivity, specificity and accuracy are indispensable in the TB control program, even as to achieve rapid detection of Mycobacterium tuberculosis in patients and characterization of drug resistance in the clinical isolates. BACTEC MGIT 960 TB System is considered a simple and fast in-vitro diagnostic instrument, designed and optimized for the fast detection of mycobacteria from clinical specimens (Somoskövi ). Resazurin Microtiter Assay (REMA) is a simple and inexpensive method utilizing resazurin, a redox indicator (Franzblau ), to test the antimicrobial activity of drugs against clinical isolates of M. tuberculosis in low-income countries (Palomino ). We aimed to assess the performance of the REMA method in determining patterns of susceptibility to four first-line drugs in M. tuberculosis clinical isolates from Brazil, by comparison with BACTEC MGIT 960, taken as a gold standard employing Minimum Inhibition Concentration (MIC) estimation and cut-off values for each drug. Eighty M. tuberculosis clinical isolates from Clemente Ferreira Institute located in São Paulo city were analyzed by the BACTEC MGIT 960 kit and REMA method to determine their susceptibility patterns to the drugs INH, RMP, streptomycin (STR) and EMB. Multi-drug resistance (MDR) was taken to be resistance to at least INH and RMP. Reference susceptibility patterns were obtained with BACTEC MGIT 960, performed at the Clemente Ferreira Institute, the TB reference center for São Paulo (SP) state, utilizing commercial kits supplied with fixed concentrations of 0.1 μg/mL, 1.0 μg/mL, 1.0 μg/mL and 5.0 μg/mL, for INH, RMP, STR and EMB, respectively (Siddiqi ). REMA (Palomino ) was carried out with a standardized bacterial inoculum, 96-well plate (Nunc Thermo Fisher Scientific, Waltham, MA) and resazurin (Sigma-Aldrich, Steinheim, Germany) as developing agent, to reveal bacterial viability and growth. Each test was carried out in triplicate. MIC was defined as the lowest concentration that inhibited 90% of M. tuberculosis growth (Palomino ). Comparative analysis between the BACTEC MGIT 960 kit and REMA data allowed the breakpoint concentration to be determined with the MedCalc Software (Mariakerke, Belgium), by means of the Receiver Operating Characteristic (ROC) curve. Accuracy of REMA was evaluated from the area under the curve (AUC): 1 - 0.9 = excellent; 0.9 - 0.8 = good; 0.8 - 0.7 = moderate and < 0.7 weak correlation. Among the eighty M. tuberculosis clinical isolates, BACTEC MGIT 960 detected 57 (71.2%) INH-resistant isolates, 49 (61.2%) RMP-resistant isolates, 29 (36.2%) STR-resistant isolates, 21 (26.2%) EMB-resistant isolates and 48 (60%) MDR isolates (Table 1). REMA determined the MIC values and the MedCalc Software determined cut-off values for each drug, based on the ROC curve concept (Table 1). ROC curve analysis resulted in sensitivity of 100%, 97.2%, 92.6% and 89.5%, specificity of 100%, 100%, 90% and 56.4% and accuracy levels of excellent, excellent, good and reasonable, with cut-off values of 0.0625 μg/mL, 0.125 μg/mL, 0.25 μg/mL and 8 μg/mL for INH, RMP, STR and EMB, respectively. Once the values had been fixed, all clinical isolates were classified as sensitive or resistant, according to their MIC values. REMA results demonstrated that, among the 80 M. tuberculosis clinical isolates, 63 (75%) were INH-resistant, 41 (51.2%) were RMP-resistant, 43 (53.7%) were STR-resistant and 47 (58.7%) were EMB-resistant. Simultaneous resistance to INH and RMP was found in 39 (48.7%) isolates, thus considered as MDR (Table 1). Some authors (5, 3, 8) based on these observations have proposed the existence of three categories of susceptibility: susceptible, partially resistant (isolates with MICs close to the cut-off value) and resistant (Mengatto ).
Table 1

Results for 80 M. tuberculosis clinical isolates analyzed by BACTEC MGIT 960 and REMA.

DrugBACTEC MGIT 960 resistanceREMA resistanceStatistical analysis cut-off value (μg/mL)
INH57 (71.2%)63 (75%)> 0.0625
RMP49 (61.2%)41 (51.2%)> 0.125
STR29 (36.2%)43 (53.7%)> 0.25
EMB21 (26.2%)47 (58.7%)> 8
MDR48 (60%)39 (48.7%)
Based on a sub-classification (Palomino , Tudó ) of resistant isolates by REMA, a division was made between high and low resistance, with cut-off values of 1 μg/mL, 2 μg/mL, 1 μg/mL and 16 μg/mL, for INH, RMP, STR and EMB, respectively. As result of this sub-classification, the resistant isolates were divided into: 53 (84.1%) INH high-resistance and 10 (15.8%) INH low-resistance (Figure 1a); 30 (73.1%) RMP high-resistance and 11 (26.8%) RMP low-resistance (Figure 1b); 19 (44.1%) STR high-resistance and 24 (55.8%) STR low-resistance (Figure 1c) and 40 (85.1%) EMB high-resistance and 7 (14.8%) EMB low-resistance (Figure 1d).
Figure 1

Sub-classification within resistant isolates by REMA. (a) INH-resistant isolates. (b) RMP-resistant isolates. (c) STR-resistant isolates. (d) EMB-resistant isolates. Full circles represent high-resistant isolates and empty circles represent low-resistant isolates.

The high percentage of MDR isolates found in this study was probably related to the main objective of the Clemente Ferreira Institute, to assist TB patients with a difficulty history of TB treatment. Studies performed in the period from 1995 to 1998 also revealed a high prevalence of MDR cases (Melo ), characterized mainly by treatment failure and abandoned and inappropriate prescriptions (Jardim ). Drug susceptibility patterns of M. tuberculosis clinical isolates were tested by REMA because this methodology enables the resistance level to be assessed with more precision in terms of MIC values (Heifets, 1988). The correct evaluation of the MIC is important because if resistant strains are classified as sensitive, the treatment will not reduce the patient’s suffering and this resistant strain will spread to other people. Besides that, if sensitive strains are classified as resistant, the patient will be treated with unnecessarily toxic and expensive drugs, resulting in overload of the health system (Ahmad ) and patients with collateral effects. Cut-off values found in this paper were lower than those reported by other authors (Montoro , Jadaun ). Such differences probably arise bacterial populations coming from different sources, with different susceptibility patterns and proportions of resistant isolates in each study, resulting in different cut-off values for each drug. Despite the discrepancies found, the authors agree that REMA is a fast method for MDR strain detection (Montoro , Jadaun , Rivoire ). For INH, there were no discordant results between REMA and BACTEC MGIT 960 (Table 2) and the sensitivity and specificity of REMA were excellent. Similar results are found in the literature (Palomino , Luna-Herrera , Montoro , Mengatto , Nateche , Rivoire ), indicating the viability of REMA in testing patterns of susceptibility to INH, even though cut-off values range between 0.0625 and 0.225 μg/mL and different results for sensitivity and specificity are found in the literature. RMP showed one discrepancy (1 false sensitive) (Table 2), resulting in a lower sensitivity than that of INH, but with the same specificity and also excellent correlation, with similar results for sensitivity (95%) and specificity (100%) in the literature (Palomino , Luna-Herrera , Montoro , Nateche , Rivoire ), as well as excellent correlation (Palomino , Luna-Herrera , Mengatto ). For STR, there were 4 discordant results (1 false resistant and 3 false sensitive) (Table 2), resulting in lower values of both sensitivity and specificity and excellent correlation, with similar published results ranging between 88.5 and 100% (Palomino , Luna-Herrera , Montoro , Nateche , Rivoire ), as well an excellent correlation (Luna-Herrera ). EMB showed 26 discordant results (3 false resistant and 23 false sensitive) (Table 2), resulting in a lower value of sensitivity, low value of specificity (Montoro ) and reasonable correlation; previous sensitivity results ranged between 92 and 98% (6, 8, 13), specificity results between 98 and 100% (Luna-Herrera , Jadaun ) and correlation was reasonable (Madison ). According to the literature, the INH high-resistance isolates showed similar results to those of Palomino et al. (Palomino ), RMP and STR high-resistance isolates showed worse results than Palomino and Tudó , respectively, and EMB high-resistance isolates showed similar results to those of Siddiqi .
Table 2

Results from 80 M. tuberculosis clinical isolates analyzed by BACTEC MGIT 960 and REMA showing numbers of agreements and disagreements results.

INHRMPSTREMB




REMARSRSRSRS
R4103502631323
S016121127318
Total4116362127301641
STR and EMB, but especially EMB, have important factors that may have contributed to the discrepancies in the results: (i) a small proportion of drug-resistant strains in the population studied, (ii) substantial differences in the volume of medium utilized by the two methods, and (iii) different periods of incubation, which may result in different degrees of degradation of the drugs (Mengatto ). Partially resistant isolates with borderline MICs were not found in this study, so that MIC values were well defined as susceptible or resistant. Furthermore, some authors have shown that these “borderline” cultures, more frequently associated with EMB resistance, have classically caused problems in the interpretation of EMB susceptibility testing (Siddiqi ), adversely affecting the overall performance of the assay. On the other hand, for STR, a low level of sensitivity was obtained. Finally, our results demonstrate that REMA is a rapid method for the determination of the susceptibility to drugs of M. tuberculosis clinical isolates in reference laboratories such as Clemente Ferreira Institute, which shows a high level of accuracy when compared with BACTEC MGIT 960, except in tests with the drug EMB.
  19 in total

1.  Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis.

Authors:  J Luna-Herrera; G Martínez-Cabrera; R Parra-Maldonado; J A Enciso-Moreno; J Torres-López; F Quesada-Pascual; R Delgadillo-Polanco; S G Franzblau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

2.  Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers.

Authors:  Farida Nateche; Anandi Martin; Saliha Baraka; Juan Carlos Palomino; Safia Khaled; Françoise Portaels
Journal:  J Med Microbiol       Date:  2006-07       Impact factor: 2.472

3.  Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis.

Authors:  Luciano Mengatto; Yosena Chiani; María Susana Imaz
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-08       Impact factor: 2.743

4.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Qualitative and quantitative drug-susceptibility tests in mycobacteriology.

Authors:  L Heifets
Journal:  Am Rev Respir Dis       Date:  1988-05

6.  Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.

Authors:  Ernesto Montoro; Dihadenys Lemus; Miguel Echemendia; Anandi Martin; Françoise Portaels; Juan Carlos Palomino
Journal:  J Antimicrob Chemother       Date:  2005-02-24       Impact factor: 5.790

7.  Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.

Authors:  L B Heifets; P J Lindholm-Levy; M A Flory
Journal:  Am Rev Respir Dis       Date:  1990-03

8.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 9.  Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.

Authors:  B P Vareldzis; J Grosset; I de Kantor; J Crofton; A Laszlo; M Felten; M C Raviglione; A Kochi
Journal:  Tuber Lung Dis       Date:  1994-02

10.  Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.

Authors:  S Ahmad; A-A Jaber; E Mokaddas
Journal:  Tuberculosis (Edinb)       Date:  2007-02-07       Impact factor: 3.131

View more
  3 in total

1.  Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review.

Authors:  Irina Kontsevaya; Jim Werngren; Yen Holicka; Kadri Klaos; Anh Tran; Vladyslav Nikolayevskyy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-30       Impact factor: 3.267

2.  Mycobacterium tuberculosis has diminished capacity to counteract redox stress induced by elevated levels of endogenous superoxide.

Authors:  Priyanka Tyagi; Allimuthu T Dharmaraja; Ashima Bhaskar; Harinath Chakrapani; Amit Singh
Journal:  Free Radic Biol Med       Date:  2015-03-27       Impact factor: 7.376

3.  Direct Resazurin Microplate Assay in Drug Susceptibility Testing of Smear-Positive Sputum Samples against Mycobacterium tuberculosis.

Authors:  Noor Izani Noor Jamil; Wan Nor Amilah Wan Abdul Wahab; Ibyhaslin Alyani Ali; Mohammad Lukman Yahaya
Journal:  Malays J Med Sci       Date:  2018-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.